Date published: 2025-12-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

LYSMD1 Inhibitors

LYSMD1 inhibitors are a class of chemical compounds that target and regulate the function of the LYSMD1 protein, which is a member of the LysM domain-containing proteins. LYSMD1, like other proteins in this family, is characterized by the presence of the LysM domain, a conserved structural motif that mediates binding to specific carbohydrate ligands such as peptidoglycans. This protein is involved in various molecular processes, particularly in the recognition and interaction with components of the cell wall. The inhibitors of LYSMD1 interfere with the protein's ability to engage in these interactions, thereby affecting downstream signaling pathways. Given its role in fundamental molecular recognition processes, LYSMD1 inhibition can modulate certain cellular activities, particularly those related to cell wall interactions and carbohydrate metabolism.

Chemically, LYSMD1 inhibitors can vary significantly in structure, but they often feature motifs that mimic or block the natural ligands of the LysM domain, thereby competitively inhibiting the binding process. These compounds are designed to either directly bind to the LysM domain or indirectly affect its structure through allosteric modulation. This leads to alterations in protein conformation and activity, reducing the LYSMD1-mediated binding affinity for its natural ligands. Such inhibition can lead to broader changes in cell signaling, as the disruption of LYSMD1 activity can affect multiple pathways associated with cell wall recognition and remodeling. The specificity of these inhibitors for the LysM domain makes them valuable tools for probing the fundamental biological roles of LYSMD1 in non-therapeutic research settings.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Torin 1

1222998-36-8sc-396760
10 mg
$240.00
7
(1)

Torin 1 is a potent inhibitor of mTORC1/2, leading to the downregulation of mTOR signaling. LYSMD1's functional role, potentially connected to mTOR pathways, would be inhibited as a result.

ZSTK 474

475110-96-4sc-475495
5 mg
$75.00
(0)

ZSTK474 is a PI3K inhibitor that reduces AKT phosphorylation and activity. This would lead to the inhibition of downstream signaling pathways required for LYSMD1's involvement in cellular processes.